Document is current

Article History

Received: 13 June 2024

Accepted: 14 September 2024

First Online: 6 October 2024

Declarations

:

: All experiments were performed in accordance with relevant guidelines and regulations<b>.</b> The study was carried out within the framework of the National Agency Santé Publique France and the National Program for the Prevention of Healthcare-associated Infections (national Health Strategy 2022–2025), which advocates for regular evaluation of healthcare professionals’ practices by local infection control teams. All work related to this program was authorized by the CNIL (National Commission on Informatics and Liverties; file 2212596 dates March 27, 2019). The protocol for the CleanHandPROX study was approved on March 8, 2022, by an ethics committee/institutional review board during a meeting of the scientific council of Santé Publique France, which is responsible for overseeing the implementation of the SPIADI program. The implementation of the study was monitored by the scientific committee overseeing the SPIADI program (January 17, 2023). At the local level, participation in the study required written commitment from the hospital director and the infection control team leader. The commiment charters were collected at the national level by the SPIADI team. In the departments where the study was conducted, the observed professionals were informed about the study (observational component, microbiological component). Informed consent was obtained from all observed professionals and all subjects for whom the central line proximal manipulation was observed and/or their legal guardian(s).

: Not applicable.

: The authors declare that they have no competing interests.